Today: 30 April 2026
JPMorgan stock heads into Tuesday with Trump lawsuit threat and credit-card cap in focus
18 January 2026
2 mins read

JPMorgan stock heads into Tuesday with Trump lawsuit threat and credit-card cap in focus

New York, January 18, 2026, 10:08 EST — Market closed.

  • JPMorgan shares ended the session roughly 1% higher, closing at $312.47.
  • Trump said he intends to sue JPMorgan within two weeks over alleged “debanking.” CEO Jamie Dimon responded, “There was no job offer” for the Fed chair position.
  • Banks want clear guidance on Trump’s plan to cap credit card interest rates at 10% for one year, beginning January 20.

JPMorgan Chase & Co. shares closed up roughly 1% at $312.47. The bank faces renewed political drama ahead of next week after President Donald Trump announced plans to sue over alleged “debanking” within two weeks. CEO Jamie Dimon pushed back, saying, “There was no job offer,” while the bank stated accounts shouldn’t be closed based on political or religious beliefs. Reuters

U.S. stock markets will remain closed Monday in observance of Martin Luther King Jr. Day, delaying trading until Tuesday. Investors get an additional day to digest weekend news before the market reopens.

Bank stocks remain caught up in policy uncertainty, not market moves. Trump plans to cap credit card interest rates at 10% for a year starting January 20, but the White House hasn’t detailed enforcement yet, and experts say Congress would likely have to approve it. Stephen Biggar of Argus Research commented, “I think there will be an ongoing conversation between the industry and the administration.” Brian Mulberry at Zacks Investment Management warned that “policy volatility” will probably keep shares on edge. Moshe Orenbuch from TD Cowen noted a 10% rate cap would lead to “less robust” card features. Reuters

JPMorgan capped the week by spotlighting growth in a fresh area. It announced a new private capital advisory & solutions team, designed to assist companies and sponsors in raising funds outside public stock exchanges. Keith Canton will lead the effort, which merges private-capital advisory with M&A services. “Private markets are a strategic priority for J.P. Morgan,” said Anu Aiyengar, head of global advisory and M&A. Reuters

On Friday, JPMorgan’s major rivals showed mixed results. Bank of America ended up roughly 0.7%, Citigroup rose near 0.5%, while Wells Fargo dropped around 0.7%.

Heading into the long weekend, trading was uneven. U.S. stocks closed Friday close to unchanged. The S&P 500 financial sector ticked higher that day but still posted its steepest weekly drop since October, weighed down by concerns over the proposed cap on credit-card rates.

The week ahead won’t offer an easy trade. Should the cap plan pick up steam, or if banks end up rolling out low-rate cards with fewer perks, it could tighten a key revenue stream that cushions slower loan growth. Traders would then begin recalculating the impact on earnings power.

Headline risk lurks outside the scope of models. Even without a court case, a lawsuit threat from the White House targeting the largest U.S. bank can weigh on the stock. It drags Washington back into focus just when investors crave stability and fewer shocks.

Tuesday’s reopening is the immediate hurdle, with investors focused on fresh updates from the administration about the credit-card initiative and how the sector reacts. The next big macro event comes with the Federal Reserve’s policy meeting on January 27-28, followed by a press conference on January 28.

Stock Market Today

  • Booking Holdings Stock Falls After Revenue Forecast Cut Amid Middle East Conflict
    April 30, 2026, 9:16 AM EDT. Booking Holdings (BKNG) shares dropped following a cut in its annual revenue growth forecast, attributed to disruptions from the ongoing Middle East conflict. The company now expects high single-digit revenue growth, down from low double digits. In Q1, room-night growth fell by about 2 percentage points due to cancellations and lower bookings, especially in March. Despite this, Q1 earnings exceeded estimates with adjusted EPS of $1.14 and revenue of $5.53 billion. CEO Glenn Fogel expressed confidence in recovery, noting U.S. room-night growth remained strong. Booking repurchased $3.6 billion in shares, underscoring management's belief in long-term value amid short-term geopolitical challenges.

Latest article

US Dollar Drops as GDP Miss and Core PCE Jump Cloud Fed Cut Bets

US Dollar Drops as GDP Miss and Core PCE Jump Cloud Fed Cut Bets

30 April 2026
The U.S. dollar fell Thursday after first-quarter GDP growth missed forecasts and core inflation accelerated, complicating the Federal Reserve’s rate outlook. The Dollar Index dropped 0.59% to 98.33, with the dollar hitting session lows against the yen after Japanese officials hinted at intervention. The Fed held rates steady Wednesday but showed division over future cuts. U.S. GDP grew at a 2.0% annualized rate, while core PCE inflation jumped to 4.3%.
QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Walmart stock price: leadership shake-up hits as Nasdaq-100 debut looms
Previous Story

Walmart stock price: leadership shake-up hits as Nasdaq-100 debut looms

Samsung Electronics stock eyes Monday test after 3.5% jump as U.S. chip tariffs loom
Next Story

Samsung Electronics stock eyes Monday test after 3.5% jump as U.S. chip tariffs loom

Go toTop